Skip to main content

Table 2 Characteristics of studies included in this review

From: Lymphadenectomy after a positive sentinel node biopsy in patients with cutaneous melanoma. A systematic review

Author Median Age (years) Gender Tumor location Breslow Thickness (mm) Ulceration % 1 positive SLN SLN metastasis
≤ 1 mm
year Obs. CLND Female Male Extremity Head & neck Trunk Obs. CLND Obs. CLND Obs. CLND
Bamboat (Bamboat et al., 2014) 66 (8–95) 56 (7–90) 185 (37%) 310 (63%) 231 (47%) 58 (12%) 182 (37%) 2.8 218/446 (49%) 380 (77%) 230 (46%)
2.8 (0.7–18) 2.8(0.7–38) 77 (46%) 141 (44%) 134 (80%) 246 (75%)
Satzger (Satzger et al., 2014) 64 (10–91) 60 (18–87) 141 (46%) 164 (54%) 154(50%) 21(7%) 130 (43%)   122 (40%) 243 (80%)  
2.3 (1.0–13) 2.6 (1.0–17) 22 (38%) 100 (40%) 51 (88%) 192 (78%)
Ploeg (van der Ploeg et al., 2014) 52.3 ± 15.3b 702(46%) 837(54%) 779(51%) 211(14%) 533(35%) 2.95 (1.80–4.50) 655/1436 (46%) 1030 (79%) 811(53%)
Melstrom (Melstrom et al., 2014) 55 (19–89) 25 (26%) 72 (74%) 16 (17%) 13 (13%) 68 (70%) 3.2 (0.8–12) 49 (51%)   
58 (19–89) 53 (24–77) 4.2(1.2–10.5) 3 (0.8–12) 7(33%) 42 (55%)
Gyorki (Gyorki et al., 2014) 66 54 14 (26%) 40 (74%) 0 54 (100%) 0 2.2 (0.9–18.0) 2.8 (1.1–15.0) 20 (37%)   
8 (44%) 12 (33%)
Fritsch (Fritsch et al., 2016) 58 (3–89) 71 (20%) 66 0 350 (100%) 0   106 /327 (32%)   
62 (3–89) 54 (11–87) 41 (32%) 65 (33%)
Mosquera (Mosquera et al., 2017) 56 843 (39%) 1329 (61%) 1051 (48%) 281 (13%) 840 (39%)   783/2131 (36%) 1586 (73%)  
59 (10–98) 55 (2–91) 34% (263) 66% (520) 590 (83%) 996 (69%)
Lee (Lee et al., 2016) 56 (7–95)a 53 (4–98)a 187 (40%) 284 (60%) 201 (43%) 76 (16%) 194 (41%) 3.1 ± 2.7 b 3.0 ± 3.6 b 135/456 (30%) 377 (80%)  
34 (35%) 101 (27%) 79 (82%) 298 (80%)
Faries (Faries et al., 2017) 54.9 (19–76) 53.7 (18–76) 728 (41%) 1027 (59%) 709 (40%) 241 (14%) 805 (46%) 2.10 (0.35–30.0) 2.10 (0.34–28.0) 669 (38%) 1239/1564 (79%) 786/1189 (66%)
353 (38%) 316 (38%) 643 (69%) 596 (72%)
Klemen (Klemen et al., 2019) 54.5 (42.4–66.7)a 376 (39%) 577 (61%) 428 (45%) 126 (13%) 397 (42%) 2.5 (1.4–4.1)a 120 /588 (13%)   
64 (51–75)a 53.6 (41.6–65.1)a 2.4 (1.4–4.5)a 2.5 (1.4–4)a 13 (11%) 107 (13%)
Leiter (Leiter et al., 2019) 54 (45–66.5)a 182 (38%) 291 (62%) 226 (48%) 0 247 (52%) 2.4 (1.6–4)a 185 (39%) 435 (92%) 311(66%)
56 (45–66)a 57 (47–67.8)a 2.4 (1.5–3.85)a 2.4 (1.6–4)a 95 (41%) 90 (38%) 213 (91%) 222 (91%)
  1. Obs Observation, RCT Randomized Clinical Trial
  2. Values are median (Range) unless otherwise are indicated. a Median (Interquartilare Range). b Mean (Estándar desviation)
\